HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

indazolium trans- (tetrachlorobis(1H- indazole)ruthenate (III))

anticancer ruthenium compound
Also Known As:
KP 1019; KP-1019; KP1019
Networked: 20 relevant articles (0 outcomes, 5 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Keppler, Bernhard K: 7 articles (07/2014 - 08/2005)
2. Jakupec, Michael A: 4 articles (07/2014 - 08/2005)
3. Berger, Walter: 4 articles (01/2014 - 10/2008)
4. Keppler, B K: 4 articles (01/2009 - 01/2003)
5. Jakupec, M A: 4 articles (01/2009 - 01/2003)
6. Hartinger, Christian G: 3 articles (07/2014 - 03/2006)
7. Heffeter, Petra: 3 articles (01/2014 - 06/2010)
8. Stultz, Laura K: 2 articles (01/2015 - 01/2013)
9. Hanson, Pamela K: 2 articles (01/2015 - 01/2013)
10. Miller, Mary E: 2 articles (01/2015 - 01/2013)

Related Diseases

1. Neoplasms (Cancer)
2. Carcinoma (Carcinomatosis)
3. Neoplasm Metastasis (Metastasis)
4. Colorectal Neoplasms (Colorectal Cancer)
5. Hypersensitivity (Allergy)

Related Drugs and Biologics

1. Ruthenium
2. DNA (Deoxyribonucleic Acid)
3. Cisplatin (Platino)
4. imidazolium- bis(imidazole)dimethylsulfoxideimidazotetrachlororuthenate(III) (NAMI-A)
5. Carrier Proteins (Binding Protein)
6. KP 1339
7. Sodium
8. Transferrin Receptors (Transferrin Receptor)
9. Proteins (Proteins, Gene)
10. Polysorbates (PSML)

Related Therapies and Procedures

1. Investigational Therapies (Experimental Therapy)